Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 2148 (LINC02148) is a human long non-coding RNA (lncRNA) gene located intergenically and does not encode a protein[3][5][7]. It has been also referred to as "HNCAT21," "CTD-3179P9.2," and "head and neck cancer-associated transcript 21".[7] LINC02148 is part of the lncRNA class of regulatory molecules, and its specific biological roles are currently not well-characterized. Preliminary associations have been described between LINC02148 and head and neck cancers, suggesting it may be relevant in tumor biology or gene regulation in these contexts, but it is not considered a direct therapeutic target such as a receptor, enzyme, or kinase[7]. No validated drugs are known to interact with LINC02148, and there are no established clinical biomarkers or safety concerns specific to this RNA at present.
Not applicable/unknown
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 2148 (LINC02148).